Published in Women's Health Weekly, February 26th, 1996
Investigators reported an apparent survival advantage for patients with metastatic cancer of the breast or ovary who developed a strong vaccine-induced antibody response against Theratope vaccine. These patients showed a statistically significant improvement in survival over patients who did not develop a strong immune response to the Theratope vaccine treatment, suggesting there is an association between antibody production against the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.